On Jan 5, 2022 Life Biosciences closed a Series C round and raised $82,000,000 from Alpha Wave Ventures, George Godula, featuring lead investors Alpha Wave […]
Series D – mPharma
On Jan 5, 2022 mPharma closed a Series D round and raised $30,000,000 from JAM Fund, Lux Capital, northstar.vc, Novastar Ventures, Social Capital, TO Ventures, […]
Series C – Atom Bioscience & Pharmaceutical
On Jan 5, 2022 Atom Bioscience & Pharmaceutical closed a Series C round and raised $45,000,000 from EFung Capital, Kaitai Capital, Livzon Pharmaceutical Group, Oriza […]
Series C – Virtual Incision
On Nov 30, 2021 Virtual Incision closed a Series C round and raised $46,000,000 from Baird Capital, Bluestem Capital, Endeavour Vision, featuring lead investors Baird […]
Series E – Color
On Nov 9, 2021 Color closed a Series E round and raised $100,000,000 from Emerson Collective, General Catalyst, Kindred Ventures, T. Rowe Price, Viking Global […]
Series E – Color
On Nov 9, 2021 Color closed a Series E round and raised $100,000,000 from Emerson Collective, General Catalyst, Kindred Ventures, T. Rowe Price, Viking Global […]
Series C – Biond Biologics
On Nov 3, 2021 Biond Biologics closed a Series C round and raised $15,000,000 from Deep Insight, Harel Insurance Investments and Financial Services, Heritage Group, […]
Series D – Enlace Health
On Nov 3, 2021 Enlace Health closed a Series D round and raised $58,000,000 from Cox Enterprises, featuring lead investors Cox Enterprises. About the company: […]
Series C – Wellinks
On Nov 3, 2021 Wellinks closed a Series C round and raised $25,000,000 from Benslie Investment Group, Connecticut Innovations, HighCape Partners, Morningside Ventures, Stonehenge Capital, […]
Series C – Biond Biologics
On Nov 3, 2021 Biond Biologics closed a Series C round and raised $15,000,000 from Deep Insight, Harel Insurance Investments and Financial Services, Heritage Group, […]
